LEONARD JOHN M 4
4 · Intellia Therapeutics, Inc. · Filed Mar 4, 2025
Insider Transaction Report
Form 4
LEONARD JOHN M
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2025-03-01+196,000→ 196,000 totalExercise: $10.09Exp: 2035-02-28→ Common Stock (196,000 underlying) - Award
Common Stock
2025-03-01+136,000→ 1,077,115 total
Holdings
- 58,415(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.
- [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.
- [F3]This option was granted on March 1, 2025 with respect to shares of Common Stock, with 33% vesting on January 1, 2026 and the remaining 67% vesting in 24 substantially equal monthly installments thereafter.